Title

Providing personalised information to support quitting smoking

Principal / Lead investigator

• Dr Grace McCutchan, Cardiff University

Co-investigators

• Prof Kate Brain, Cardiff University

Type of study

Development of leaflet intervention

Summary

Lung cancer is the most common cause of cancer related death in the world. More than 85% of cases of lung cancer are caused by tobacco smoking, and stopping smoking, at any age, can reduce lung cancer risk.

By helping people to stop smoking and by inviting people to take part in lung cancer screening, lung cancer death can be reduced. However, we currently do not know the best ways to include stop smoking information in a lung cancer screening programme.

Personalised risk information that has been specially designed to predict an individual’s risk of lung and heart conditions may motivate people to stop smoking. This focus group study with smokers living in deprived communities will explore their personal experiences of trying to stop smoking in the past, and what they think of the personalised risk information.

Findings will be used to make the personalised risk information materials better. The materials may then be used for a stop smoking intervention as part of a lung cancer screening trial. 

Lay involvement

Public and patient representatives will be involved in the development of the personalised risk information materials before they are tested for acceptability in the focus groups. 

Who is the study sponsor?

Cardiff University

Does the study involve commercial partnership activity?

No

UKCRN portfolio number (if relevant)

N/A

Funder

Cardiff University Respiratory Bequest Fund

Total grant value

£2,000

Start date

01/10/2017

End date

01/12/2017

How could this research potentially benefit patients?

Evidence suggests that smoking cessation and lung cancer screening have additive effects on survival. Furthermore, stopping smoking, at any age, can significantly reduce lung cancer risk. This study will provide valuable insight into how best to present risk information to promote smoking cessation in the lung screening context and lower lung cancer risk in patients who smoke.

Further information

Research poster: http://www.cancerresearchuk.org/sites/default/files/edrc17_poster-34_grace-mccutchan_lung_cancer_awareness_intervention.pdf

Outputs generated 

Conference Abstract: McCutchan G, Wood F, Edwards A, Smits S. PUB022 Development of a Lung Cancer Awareness Intervention Targeted at Socioeconomically Deprived Communities in Wales, UK. Journal of Thoracic Oncology, Vol 12:1, S1459-S1460, Jan 2017.

Poster presentation: 'Development and pilot evaluation of a targeted cancer awareness intervention for adults living in socioeconomically deprived communities' at Cancer Research UK Early Diagnosis Research Conference, London, 23-24 February 2017. 

Impact

Findings from this study will be used to inform a future trial to explore whether the provision of personalised information, delivered by smoking cessation practitioners based in mobile screening units, increases smoking cessation rates in the context of a lung cancer screening programme. The findings would guide how smoking cessation can be integrated into a future LDCT screening programme in the UK to maximise patient benefit.